Are HMAS appropriate for posttransplant maintenance in acute leukemias?November 5, 2020Leukemia, Myelodysplasia, Transplantation
Novel agents hold promise for frontline AML treatmentOctober 28, 2020Leukemia, Myelodysplasia, Transplantation
Novel treatments under study for chronic graft-versus-host disease in allo-HCTOctober 27, 2020Leukemia, Myelodysplasia, Transplantation
Final ASCEND study data: Acalabrutinib beat standard of care for r/r CLLOctober 23, 2020Leukemia, Myelodysplasia, Transplantation
Are oncologists ready to confront a second wave of COVID-19?October 21, 2020Practice ManagementBreast CancerCNS/Brain CancerCOVID-19 UpdatesGastroenterologyGenitourinary CancerGynecologic Cancer
ESMO offers new clinical practice guideline for CLLOctober 21, 2020Leukemia, Myelodysplasia, Transplantation
Can AML patients be too old for cell transplantation?October 20, 2020Leukemia, Myelodysplasia, Transplantation
Study: Complications from childhood ALL and its treatment are common, but can be managedOctober 15, 2020Leukemia, Myelodysplasia, Transplantation
A uniquely patient-focused take on treating AML in older adultsOctober 13, 2020Leukemia, Myelodysplasia, Transplantation
Clinical factors and treatment tied to COVID-19 mortality in cancer patientsOctober 8, 2020Patient & Survivor CareCNS/Brain CancerCOVID-19 UpdatesGastroenterologyGenitourinary CancerGynecologic CancerHead & Neck/Thyroid Cancers
Meta-analysis: Acalabrutinib showed better PFS and OS than other frontline CLL therapiesOctober 7, 2020Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
The scope of under- and overtreatment in older adults with cancerOctober 1, 2020Patient & Survivor CareBreast CancerCNS/Brain CancerGastroenterologyGenitourinary CancerGynecologic CancerHead & Neck/Thyroid Cancers
Orthopedic problems in children can be the first indication of acute lymphoblastic leukemiaSeptember 30, 2020Leukemia, Myelodysplasia, Transplantation
Cancer disparities: One of the most pressing public health issuesSeptember 30, 2020Patient & Survivor CareBreast CancerCNS/Brain CancerGastroenterologyGenitourinary CancerGynecologic CancerHead & Neck/Thyroid Cancers
Two new protein biomarkers may serve as prognostic indicators for outcomes in CLLSeptember 23, 2020Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
